ICON plc
Company typePublic
Nasdaq: ICLR
Russell 1000 component
Industry
Founded1990; 34 years ago (1990) in Dublin, Ireland
FoundersJohn Climax
Ronan Lambe
Key people
Steve Cutler, CEO
ProductsServices for pharmaceutical, biotech and medical device industries
Revenue$7.741 billion (2022)[1]
Number of employees
41,160 (2023)[1]
Websitewww.iconplc.com

ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry.[2] As of June 2023, ICON had approximately 41,160 employees in 108 locations spread across 53 countries.[1]

History

ICON was founded in Dublin, Ireland, by John Climax and Ronan Lambe in 1990.[3] Since January 2010, Climax has held a position on the board of directors. Lambe retired from the board of directors in 2018.[4]

Between 1991 and 1996, ICON opened offices in the United Kingdom, United States, Germany, and Japan.[5] Two years later, ICON shares started to be traded on Nasdaq.[6]

In 2013, PRA Health Sciences was acquired by KKR, which listed the company on the Nasdaq in November 2014 and maintained shares until September 2019.[7] In August 2017, the company acquired Conshohocken-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million.[8] PRA's 2018 revenue was US$2.87 billion.[9] PRA was acquired by ICON on 1 July 2021.[10]

In March 2017, Steve Cutler was appointed Chief Executive Officer of ICON.[11] He had previously been with Quintiles South Africa, Sandoz AG, and Kendle Intl Inc, before joining ICON Clinical Research Services in 2011, and becoming Chief Operating Officer in 2014.[12]

In 2018, ICON won PharmaTimes Clinical Researcher of the Year.[13] ICON enjoyed success in multiple categories at the Clinical Research Organisation leadership awards,[14] consecutively from 2018 - 2023, determined by Life Science Leader magazine and Industry Standard Research (ISR). In 2021, ICON was awarded PharmaTimes Clinical Research Company of the Year,[15] and in 2022, won Best Contract Research Organisation (FSP) [16] at the Scrip Awards.

Acquisitions

See also

References

  1. ^ a b c "Facts and figures". ICON plc. Retrieved 2021-11-21.
  2. ^ "ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research". www.businesswire.com. 2021-02-24. Retrieved 2021-07-01.
  3. ^ "Icon founders poised to make $45m in share placing". Irish Times. 24 July 2003. Retrieved 8 December 2019.
  4. ^ "Board of Directors". Red Robin Gourmet Burgers, Inc. 2023. Retrieved 2023-11-01.
  5. ^ Langan, Sheila (1 October 2014). "ICON of Ireland". Irish America. Retrieved 8 December 2019.
  6. ^ "ICON plc : ICON Announces the Commencement of Direct Trading on NASDAQ". Market Screener. 5 February 2013. Retrieved 8 December 2019.
  7. ^ "PRA Health Sciences Announces Secondary Offering and Concurrent Share Repurchase". Globenewswire. September 3, 2019.
  8. ^ Liu, Angus (August 8, 2017). "PRA Health Sciences makes $530M Symphony buy, reports 16% revenue growth in Q2". FierceBiotech.
  9. ^ "Investors | ICON PLC".
  10. ^ "ICON acquisition creates world-leading healthcare intelligence and clinical research organisation" (Press release). 1 July 2021.
  11. ^ "BRIEF-ICON says Steve Cutler to be named CEO". Reuters. 20 October 2016. Retrieved 8 December 2019.
  12. ^ "Profile Stephen A Cutler "Steve"". www.bloomberg.com. n.d. Retrieved 28 November 2021.
  13. ^ "Winner 2018". Pharma Times. December 2018. Retrieved 8 December 2019.
  14. ^ "ICON Wins Multiple Categories in 2019 CRO Leadership Awards". BusinessWire. 5 March 2019. Retrieved 8 December 2019.
  15. ^ "Clinical Researcher of the Year - The Americas 2021 winners announced". Pharma Times. October 2021. Retrieved 29 October 2021.
  16. ^ "Scrip Awards 2022 Winners have been Announced". Pharma Intelligence UK Limited. November 2022. Retrieved 30 November 2022.
  17. ^ "YRCR was acquired by Icon on February 3, 2000". Mergr. Retrieved 8 December 2019.
  18. ^ Barrington, Kathleen (10 June 2000). "Icon buys UCT for $2m cash plus $18m deferred payments". Independent. Retrieved 8 December 2019.
  19. ^ McGrath, Brendan (1 February 2000). "Icon buys US data group in first public acquisition". The Irish Times. Retrieved 8 December 2019.
  20. ^ "Form 20-F". Securities and Exchange Commission. United States Government. Retrieved 8 December 2019.
  21. ^ "Form 20-F". Securities and Exchange Commission. United States Government. Retrieved 8 December 2019.
  22. ^ "ICON Acquires GloboMax". Mergr. Retrieved 8 December 2019.
  23. ^ "Beacon Bioscience Acquired by ICON July 1, 2004". Crosstree Capital. Retrieved 8 December 2019.
  24. ^ "ICON Acquires Ovation Research Group". Mergr. Retrieved 8 December 2019.
  25. ^ Mansell, Peter (16 July 2007). "ICON acquires clinical research staffer DOCS International". Pharma Times. Retrieved 8 December 2019.
  26. ^ "ICON Acquires Healthcare Discoveries". Contract Pharma. 12 February 2008. Retrieved 8 December 2019.
  27. ^ MacDonald, Gareth (22 October 2009). "Icon boosts bioanalytical presence through Prevalere buy". Outsourcing Pharma. Retrieved 8 December 2019.
  28. ^ "ICON Acquires Veeda Laboratories Ltd". Biospace. 8 December 2008. Retrieved 8 December 2019.
  29. ^ Rhea, Shawn (24 May 2010). "Icon acquires Timaq Medical Imaging". Modern Healthcare. Retrieved 10 December 2019.
  30. ^ Mansell, Peter (18 January 2011). "ICON broadens late-phase expertise with Oxford Outcomes acquisition". PharmaTimes. Retrieved 10 December 2019.
  31. ^ Lynch, Suzanne (15 July 2011). "Pharmaceutical firm Icon buys Firecrest Clinical for undisclosed sum". The Irish Times. Retrieved 10 December 2019.
  32. ^ "ICON-PLC Acquires PriceSpective". Biospace. 28 February 2012. Retrieved 10 December 2019.
  33. ^ "ICON Acquires BeijingWits Medical Consulting Ltd". BioSpace. 12 December 2011. Retrieved 10 December 2019.
  34. ^ "DOCS Acquires ClinForce and Assent Consulting". DOCS Global. DOCS. Retrieved 10 December 2019.
  35. ^ Mansell, Peter (5 February 2013). "Icon to acquire Cross Country's Clinical Trial Services Division". PharmaTimes. Retrieved 10 December 2019.
  36. ^ Mansell, Peter (1 April 2014). "ICON to acquire Aptiv Solutions for US$143.5 million". PharmaTimes. Retrieved 10 December 2019.
  37. ^ "ICON Completes Acquisition Of MediMedia Pharma Solutions". BioSpace. 2 March 2015. Retrieved 10 December 2019.
  38. ^ "ICON Acquires PMG Research". Contract Pharma. 7 December 2015. Retrieved 10 December 2019.
  39. ^ "ICON Completes the Acquisition of Clinical Research Management, Inc". BusinessWire. 19 September 2016. Retrieved 10 December 2019.
  40. ^ "ICON Acquires Mapi Group". Health Economics. Retrieved 10 December 2019.
  41. ^ "Symphony Clinical Research Acquired by ICON". Symphony Clinical Research. Retrieved 10 December 2019.
  42. ^ "ICON's Acquisition of MeDiNova Research". Bloomberg. 23 May 2019. Retrieved 10 December 2019.
  43. ^ Pennic, Fred (21 February 2019). "ICON Acquires Precision Medicine for Oncology Company MolecularMD". HIT Consultant. Retrieved 10 December 2019.
  44. ^ "ICON Acquires MedPass International". Bloomberg. Retrieved 19 February 2020.
  45. ^ "ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research". www.businesswire.com. 2021-02-24. Retrieved 2021-07-01.
  46. ^ Parsons, Lucy (2021-02-26). "ICON to acquire PRA Health Sciences in $12bn deal". PharmaTimes. Retrieved 2021-10-19.

External links

Contract research organization
Kohlberg Kravis Roberts
Categories